FAP and neoplasm: Regarding NAC response assessment, Backhous and colleagues presented initial results using [68Ga]-labeled FAP inhibitor (FAPI) PET/MRI in 13 women: the mean breast-tumor-to-background ratio was 0.9 for pCR and 2.1 for non-pCR (p = 0.001).